RGS2 ggenetic variation: Association analysis with panic disorder and dimensional as well as intermediate phenotypes of anxiety

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 168, Issue 3, 2015, Pages 211-222

  Hohoff, Christa ^a   Weber, Heike ^b,c   Richter, Jan ^d   Domschke, Katharina ^b   Zwanzger, Peter M ^a   Ohrmann, Patricia ^a   Bauer, Jochen ^a   Suslow, Thomas ^a,e   Kugel, Harald ^a   Baumann, Christian ^b   Klauke, Benedikt ^a,f   Jacob, Christian P ^b   Fritze, Jürgen ^g   Bandelow, Borwin ^h   Gloster, Andrew T ⁱ   Gerlach, Alexander L ^j   Kircher, Tilo ^k   Lang, Thomas ^l,m   Alpers, Georg W ^b,n   Ströhle, Andreas ^o   Fehm, Lydia ^p   Wittchen, Hans Ulrich ⁱ   Arolt, Volker ^a   Pauli, Paul ^b   Hamm, Alfons ^d   Reif, Andreas ^b   Deckert, Jürgen ^b   more..

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d UNIVERSITY OF GREIFSWALD   (Germany)

^e UNIVERSITY OF LEIPZIG   (Germany)

^f Christoph Dornier Clinic for Psychotherapy   (Germany)

^g GOETHE UNIVERSITY   (Germany)

^h UNIVERSITY OF GÖTTINGEN   (Germany)

ⁱ DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^j UNIVERSITY OF COLOGNE   (Germany)

^k PHILIPPS UNIVERSITY MARBURG   (Germany)

^l Christoph Dornier Foundation for Clinical Psychology   (Germany)

^m UNIVERSITY OF BREMEN   (Germany)

ⁿ UNIVERSITY OF MANNHEIM   (Germany)

^o CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^p HUMBOLDT UNIVERSITY   (Germany)

more..

Author keywords

Anxiety; Fear; Panic disorder; Polymorphism; Regulator of G protein signaling 2

Indexed keywords

RGS2 PROTEIN; BIOLOGICAL MARKER; RGS PROTEIN; RGS2 PROTEIN, HUMAN;

ADULT; AGORAPHOBIC COGNITIONS QUESTIONNAIRE; ANTICIPATORY ANXIETY; ANXIETY SENSITIVITY INDEX; ARTICLE; ASSESSMENT OF HUMANS; BEHAVIORAL AVOIDANCE TEST; CASE CONTROL STUDY; CONTROLLED STUDY; DSM-III-R; DSM-IV; ELECTROENCEPHALOGRAM; EMOTION; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANIC; PHENOTYPE; PILOT STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURED INTERVIEW; ANXIETY DISORDERS; BRAIN MAPPING; COMPARATIVE STUDY; COMPLICATION; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; IMAGE PROCESSING; PERSONALITY; PHYSIOLOGY; PROGNOSIS; PSYCHOLOGIC TEST; PSYCHOLOGY;

ADULT; ANXIETY DISORDERS; BIOMARKERS; BRAIN MAPPING; CASE-CONTROL STUDIES; EMOTIONS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; PANIC DISORDER; PERSONALITY; PHENOTYPE; PILOT PROJECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PSYCHOLOGICAL TESTS; RGS PROTEINS;

EID: 84925671569     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32299     Document Type: Article

References (66)

1. Alpers GW, Pauli P. 2001. Angstsensitivitäts-Index. Würzburg: Julius-Maximilians-Universität.
2. Amstadter AB, Koenen KC, Ruggiero KJ, Acierno R, Galea S, Kilpatrick DG, Gelernter J. 2009. Variant in RGS2 moderates posttraumatic stress symptoms following potentially traumatic event exposure. J Anxiety Disord 23:369-373.
3. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
4. Brett M, Anton JL, Valabregue R, Poline JB. 2002. Region of interest analysis using an SPM toolbox. Neuroimage 16:497.
5. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T. 2005. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21:2933-2942.
6. Chambless DL, Caputo GC, Bright P, Gallagher R. 1984. Assessment of fear of fear in agoraphobics: The body sensations questionnaire and the agoraphobic cognitions questionnaire. J Consult Clin Psychol 52:1090-1097.
7. Chambless DL, Beck AT, Gracely EJ, Grisham JR. 2000. Relationship of cognitions to fear of somatic symptoms: A test of the cognitive theory of panic. Depress Anxiety 11:1-9.
8. Clark DM. 1986. A cognitive approach to panic. Behav Res Ther 24:461-470.
9. Dabrowski M, Aerts S, Kaminska B. 2006. Prediction of a key role of motifs binding E2F and NR2F in down-regulation of numerous genes during the development of the mouse hippocampus. BMC Bioinformatics 7:367.
10. Davis M, Whalen PJ. 2001. The amygdala: Vigilance and emotion. Mol Psychiatry 6:13-34.
11. Domschke K, Braun M, Ohrmann P, Suslow T, Kugel H, Bauer J, Hohoff C, Kersting A, Engelien A, Arolt V, Heindel W, Deckert J. 2006. Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal and amygdala activation measured with 3T fMRI in panic disorder. Int J Neuropsychopharmacol 9:349-355.
12. Domschke K, Ohrmann P, Braun M, Suslow T, Bauer J, Hohoff C, Kersting A, Engelien A, Arolt V, Heindel W, Deckert J, Kugel H. 2008. Influence of the catechol-O-methyltransferase val158met genotype on amygdala and orbitofrontal cortex emotional processing in panic disorder. Psychiatry Res 163:13-20.
13. Domschke K, Dannlowski U. 2010. Imaging genetics of anxiety disorders. Neuroimage 53:822-831.
14. Domschke K, Reif A, Weber H, Richter J, Hohoff C, Ohrmann P, Pedersen A, Bauer J, Suslow T, Kugel H, Heindel W, Baumann C, Klauke B, Jacob C, Maier W, Fritze J, Bandelow B, Krakowitzky P, Rothermundt M, Erhardt A, Binder EB, Holsboer F, Gerlach AL, Kircher T, Lang T, Alpers GW, Ströhle A, Fehm L, Gloster AT, Wittchen HU, Arolt V, Pauli P, Hamm A, Deckert J. 2011. Neuropeptide S receptor gene-converging evidence for a role in panic disorder. Mol Psychiatry 16:938-948.
15. Ehlers A, Margraf J, Chambless D. 1993. Fragebogen zu körperbezogenen Ängsten, Kognitionen und Vermeidung (AKV). Göttingen: Hogrefe.
16. Erhardt A, Czibere L, Roeske D, Lucae S, Unschuld PG, Ripke S, Specht M, Kohli MA, Kloiber S, Ising M, Heck A, Pfister H, Zimmermann P, Lieb R, Pütz B, Uhr M, Weber P, Deussing JM, Gonik M, Bunck M, Kebler MS, Frank E, Hohoff C, Domschke K, Krakowitzky P, Maier W, Bandelow B, Jacob C, Deckert J, Schreiber S, Strohmaier J, Nöthen M, Cichon S, Rietschel M, Bettecken T, Keck ME, Landgraf R, Müller-Myhsok B, Holsboer F, Binder EB. 2011. TMEM132D, a new candidate for anxiety phenotypes: Evidence from human and mouse studies. Mol Psychiatry 16:647-663.
17. Flint J. 2003. Analysis of quantitative trait loci that influence animal behaviour. J Neurobiol 54:46-77.
18. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, Belmont JW, Boudreau A, Hardenbol P, Leal SM. 2007. A second generation human haplotype map of over 3.1 million SNPs. Nature 449:851-861.
19. Gloster AT, Wittchen HU, Einsle F, Hofler M, Lang T, Helbig-Lang S, Fydrich T, Fehm L, Hamm AO, Richter J, Alpers GW, Gerlach AL, Ströhle A, Kircher T, Deckert J, Zwanzger P, Arolt V. 2009. Mechanism of action in CBT (MAC): Methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia. Eur Arch Psychiatry Clin Neurosci 259:155-166.
20. Gregersen N, Dahl HA, Buttenschøn HN, Nyegaard M, Hedemand A, Als TD, Wang AG, Joensen S, Woldbye DP, Koefoed P, Kristensen AS, Kruse TA, Børglum AD, Mors O. 2012. A genome-wide study of panic disorder suggests the amiloride-sensitive cation channel 1 as a candidate gene. Eur J Hum Genet 20:84-90.
21. Hamm AO, Richter J, Pané-Farré CA. 2014. When the threat comes from inside the body. A neuroscience based learning perspective of the etiology of panic disorder. Restorative Neurol Neurosci 32:79-93.
22. Hettema JM, Sun C, Chen X, Kendler KS. 2013. Genetic association study between RGS2 and anxiety-related phenotypes. Psychiatr Genet 23:92.
23. Heximer SP. 2004. RGS2-mediated regulation of Gqalpha. Methods Enzymol 390:65-82.
24. Hofmann SG, Alpers GW, Pauli P. 2008. Phenomenology of panic and phobic disorders. In: Antony MM, Stein MB, editors. Oxford handbook of anxiety and related disorders. New York: Oxford University Press pp 34-46.
25. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, de Bakker PI. 2008. SNAP: A web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24:2938-2939.
26. Kawamura Y, Otowa T, Koike A, Sugaya N, Yoshida E, Yasuda S, Inoue K, Takei K, Konishi Y, Tanii H, Shimada T, Tochigi M, Kakiuchi C, Umekage T, Liu X, Nishida N, Tokunaga K, Kuwano R, Okazaki Y, Kaiya H, Sasaki T. 2011. A genome-wide CNV association study on panic disorder in a Japanese population. J Hum Genet 56:852-856.
27. Kendler KS, Karkowski LM, Prescott CA. 1999. Fears and phobias: Reliability and heritability. Psychol Med 29:539-553.
28. Koenen KC, Amstadter AB, Ruggiero KJ, Acierno R, Galea S, Kilpatrick DG, Gelernter J. 2009. RGS2 and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults. Depress Anxiety 26:309-315.
29. Lappalainen T, Sammeth M, Friedlander MR, t Hoen, Monlong PA, Rivas J, et al. 2013. Transcriptome and genome sequencing uncovers functional variation in humans. Nature 501:(7468):506-511.
30. Larminie C, Murdock P, Walhin JP, Duckworth M, Blumer KJ, Scheideler MA, Garnier M. 2004. Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system. Brain Res Mol Brain Res 122:24-34.
31. LeDoux JE. 2000. Emotion circuits in the brain. Annu Rev Neurosci 23:155-184.
32. Leygraf A, Hohoff C, Freitag C, Willis-Owen SA, Krakowitzky P, Fritze J, Franke P, Bandelow B, Fimmers R, Flint J, Deckert J. 2006. RGS 2 gene polymorphisms as modulators of anxiety in humans? J Neural Transm 113:1921-1925.
33. Lueken U, Straube B, Konrad C, Wittchen HU, Ströhle A, Wittmann A, Pfleiderer B, Uhlmann C, Arolt V, Jansen A, Kircher T. 2013. Neural substrates of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia. Am J Psychiatry 170:1345-1355.
34. Mannuzza S, Fyer AJ, Klein DF, Endicott J. 1986. Schedule for Affective Disorders and Schizophrenia-Lifetime Version modified for the study of anxiety disorders (SADS-LA): rationale and conceptual development. J Psychiatr Res 20:317-325.
35. Menashe I, Rosenberg PS, Chen BE. 2008. PGA: Power calculator for case-control genetic association analyses. BMC Genet 9:36.
36. Mouri K, Hishimoto A, Fukutake M, Nishiguchi N, Shirakawa O, Maeda K. 2010. Association study of RGS2 gene polymorphisms with panic disorder in Japanese. Kobe J Med Sci 55:E116-E121.
37. Myers-Schulz B, Koenigs M. 2012. Functional anatomy of ventromedial prefrontal cortex: implications for mood and anxiety disorders. Mol Psychiatry 17:132-141.
38. Neubig RR, Siderovski DP. 2002. Regulators of G-protein signalling as new central nervous system drug targets. Nat Rev Drug Discov 1:187-197.
39. Oliveira-dos-Santos AJ, Matsumoto G, Snow BE, Bai D, Houston FP, Whishaw IQ, Mariathasan S, Sasaki T, Wakeham A, Ohashi PS, Roder JC, Barnes CA, Siderovski DP, Penninger JM. 2000. Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc Natl Acad Sci USA 97:12272-12277.
40. Otowa T, Yoshida E, Sugaya N, Yasuda S, Nishimura Y, Inoue K, Tochigi M, Umekage T, Miyagawa T, Nishida N, Tokunaga K, Tanii H, Sasaki T, Kaiya H, Okazaki Y. 2009. Genome-wide association study of panic disorder in the Japanese population. J Hum Genet 54:122-126.
41. Otowa T, Shimada T, Kawamura Y, Sugaya N, Yoshida E, Inoue K, Yasuda S, Liu X, Minato T, Tochigi M, Umekage T, Kasai K, Tanii H, Okazaki Y, Kaiya H, Sasaki T. 2011. Association of RGS2 variants with panic disorder in a Japanese population. Am J Med Genet B Neuropsychiatr Genet 156B:430-434.
42. Otowa T, Kawamura Y, Nishida N, Sugaya N, Koike A, Yoshida E, Inoue K, Yasuda S, Nishimura Y, Liu X, Konishi Y, Nishimura F, Shimada T, Kuwabara H, Tochigi M, Kakiuchi C, Umekage T, Miyagawa T, Miyashita A, Shimizu E, Akiyoshi J, Someya T, Kato T, Yoshikawa T, Kuwano R, Kasai K, Kato N, Kaiya H, Tokunaga K, Okazaki Y, Tanii H, Sasaki T. 2012. Meta-analysis of genome-wide association studies for panic disorder in the Japanese population. Transl Psychiatry 2:e186.
43. Pauli P, Marquardt C, Hartl L, Nutzinger DO, Hölzl R, Strian F. 1991. Anxiety induced by cardiac perceptions in patients with panic attacks: A field study. Behav Res Ther 29:137-145.
44. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. 2007. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575.
45. Ramakers C, Ruijter JM, Deprez RH, Moorman AF. 2003. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 339:62-66.
46. Reif A, Weber H, Domschke K, Klauke B, Baumann C, Jacob C, Ströhle S, Gerlach AL, Alpers GW, Pauli P, Hamm A, Kircher T, Arolt V, Wittchen HU, Binder EB, Erhardt A, Deckert J. 2012. Meta-Analysis Argues for a Female-Specific Role of MAOA-uVNTR in Panic Disorder in Four European Populations. Am J Med Genet B Neuropsychiatr Genet 159B:786-793.
47. Reiss S, Peterson RA, Gursky DM, McNally RJ. 1986. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther 24:1-8.
48. Richter J, Hamm AO, Pané-Farré CA, Gerlach AL, Gloster AT, Wittchen HU, Lang T, Alpers GW, Helbig-Lang S, Deckert J, Fydrich T, Lehm L, Ströhle A, Kircher T, Arolt V. 2012. Dynamics of defensive reactivity in patients with panic disorder and agoraphobia: Implications for the etiology of panic disorder. Biol Psychiatry 72:512-520.
49. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Towle LH. 1988. The Composite International Diagnostic Interview. An epidemiological instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 45:1069-1077.
50. Semplicini A, Lenzini L, Sartori M, Papparella I, Calò LA, Pagnin E, Strapazzon G, Benna C, Costa R, Avogaro A, Ceolotto G, Pessina AC. 2006. Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II. J Hypertens 24:1115-1124.
51. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 Suppl 20:22-33;quiz:34-57.
52. Smoller JW, Acierno JS, Jr, Rosenbaum JF, Biederman J, Pollack MH, Meminger S, Pava JA, Chadwick LH, White C, Bulzacchelli M, Slaugenhaupt SA. 2001. Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions. Am J Med Genet 105:195-206.
53. Smoller JW, Paulus MP, Fagerness JA, Purcell S, Yamaki LH, Hirshfeld-Becker D, Biederman J, Rosenbaum JF, Gelernter J, Stein MB. 2008. Influence of RGS2 on anxiety-related temperament, personality, and brain function. Arch Gen Psychiatry 65:298-308.
54. Ströhle A, Stoy M, Graetz B, Scheel M, Wittmann A, Gallinat J, Lang UE, Dimeo F, Hellweg R. 2010. Acute exercise ameliorates reduced brain-derived neurotrophic factor in patients with panic disorder. Psychoneuroendocrinology 35:364-368.
55. Strug LJ, Suresh R, Fyer AJ, Talati A, Adams PB, Li W, Hodge SE, Gilliam TC, Weissman MM. 2010. Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR). Mol Psychiatry 15:166-176.
56. Talbot CJ, Nicod A, Cherny SS, Fulker DW, Collins AC, Flint J. 1999. High-resolution mapping of quantitative trait loci in outbred mice. Nat Genet 21:305-308.
57. Tao X, West AE, Chen WG, Corfas G, Greenberg ME. 2002. A calcium-responsive transcription factor, CaRF, that regulates neuronal activity-dependent expression of BDNF. Neuron 33:383-395.
58. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M. 2002. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273-289.
59. Uitenbroek DG. 1997. SISA Binomial. Southampton: D.G. Uitenbroek. Retrieved January 01, 2013 (http://www.quantitativeskills.com/sisa/distributions/binomial.htm).
60. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034.
61. Watson N, Linder ME, Druey KM, Kehrl JH, Blumer KJ. 1996. RGS family members: GTPase-activating proteins for heterotrimeric G-protein alpha-subunits. Nature 383:172-175.
62. Wittchen HU, Garczynski E, Pfister H. 1997. Composite international diagnostic interview according to ICD-10 and DSM-IV. Göttingen: Hogrefe.
63. Wittchen HU. 1997. SKID-I: Strukturiertes Klinisches Interview Für DSM-IV, Achse I: Psychische Störungen. Göttingen: Hogrefe.
64. Yalcin B, Willis-Owen SAG, Fullerton J, Meesaq A, Deacon RM, Rawlins JNP, Copley RR, Morris AP, Flint J, Mott R. 2004. Genetic dissection of a behavioral quantitative trait locus shows that RGS2 modulates anxiety in mice. Nat Genet 36:1197-1202.
65. Yoon KL, Zinbarg RE. 2007. Threat is in the eye of the beholder: social anxiety and the interpretation of ambiguous facial expressions. Behaviour Research Therapy 45:839-847.
66. Zheng F, Zhou X, Luo Y, Xiao H, Wayman G, Wang H. 2011. Regulation of brain-derived neurotrophic factor exon IV transcription through calcium responsive elements in cortical neurons. PLoS One 6:e28441.